Plain-English translation of NCT07145632 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new smartphone app designed to teach you the correct way to use your inhaler — whether it's a dry powder inhaler (DPI) or a metered-dose inhaler (MDI). The app aims to give you personalized feedback on your breathing technique whenever you need it, even at home. Right now, healthcare providers usually teach inhaler technique in the clinic, but this app could make learning easier and more accessible.
Many people with asthma and COPD don't use their inhalers correctly, which means the medication doesn't reach their lungs properly and symptoms get worse. The new treatment could help fix this by letting patients practice and get feedback anytime, anywhere — not just during doctor visits.
You likely qualify if…
You likely don't qualify if…
You would be placed into one of two groups: either standard care (where you get regular breathing technique training from a healthcare provider) or the app-based intervention (where you use the smartphone app to learn and practice your breathing technique). The app gives objective measurements of how well you're breathing in — things that can't be measured during a regular clinic visit. You'll be asked to use the app or attend training sessions as part of the study, which typically lasts 6 to 12 weeks.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Sweden